291 results on '"Sehgal, Lalit"'
Search Results
2. Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents
3. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4
4. PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
5. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma
6. Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma
7. Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
8. A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells
9. Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer
10. Anaesthetic management of a bleeding intratracheal mass
11. RETRACTED ARTICLE: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
12. Retraction Note: Phosphor-IWS1-dependent U2AF2 splicing regulates trafficking of CAR-E-positive intronless gene mRNAs and sensitivity to viral infection
13. RETRACTED ARTICLE: Phosphor-IWS1-dependent U2AF2 splicing regulates trafficking of CAR-E-positive intronless gene mRNAs and sensitivity to viral infection
14. Direct CP Violation in B-+ -> pi-+ omega, pi-+ rho0, pi0 rho-+, and in B-bar0(B0) -> pi-+ rho+- With an Enhanced Branching Ratio for pi0 rho0
15. Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia
16. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4
17. Abstract 3689: Uncovering the metabolic vulnerabilities in activated B cell diffuse large B cell lymphoma
18. Abstract 1422: Fibroblast growth factor receptor-1 is a novel therapeutic target in mantle cell Lymphoma
19. Supplementary figure legends and materials from HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer
20. Data from HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer
21. Supplementary figure from HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer
22. Nanochip Technology for Monitoring Chemotherapy Response Using Extracellular RNAs and Proteins in Patient Plasma with Diffuse Large B-Cell Lymphoma As Biomarkers
23. Impact of Circulating Lymphoma at Diagnosis on Outcomes in Patients with Diffuse Large B-Cell Lymphoma
24. AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
25. Abstract 3019: The epigenetic factor KDM2B alters the serine-glycine synthesis pathway and the one-carbon metabolism (SGOC) in triple-negative breast cancer
26. Fizikai Szemle (Hungarian Physical Review), 2022 Special Issue
27. Additional file 1 of A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells
28. Spontaneous regression of interdigitating dendritic sarcoma in a patient with concurrent small lymphocytic lymphoma
29. Revision of Roux-en-Y-Gastric bypass – Our experience in Indian patients
30. Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer
31. PRMT5 Inhibition Promotes FOXO1 Tumor Suppressor Activity to Drive a Pro-Apoptotic Program That Creates Vulnerability to Combination Treatment with Venetoclax in Mantle Cell Lymphoma
32. Epidermal Growth Factor-like 7 As a Novel Therapeutic Target in Mantle Cell Lymphoma
33. Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease
34. Overexpression of the SETD2 WW domain inhibits the phosphor-IWS1/SETD2 interaction and the oncogenic AKT/IWS1 RNA splicing program
35. Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas
36. Generation of Transgenic Mice by Exploiting Spermatogonial Stem Cells In Vivo
37. Abstract 1114: Role of the FGFR1-KDM2B-EZH2 signaling axis in bone-marrow microenvironment mediated tumor survival & drug resistance in Mantle cell lymphoma
38. E-cadherin and plakoglobin recruit plakophilin3 to the cell border to initiate desmosome assembly
39. 90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease
40. Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma
41. Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
42. Abstract PO010: The inhibition of IWS1 phosphorylation promotes genomic instability, the cGAS/STING pathway activation and PD-L1 levels, through the U2AF2 alternative RNA splicing and Sororin expression
43. Abstract PO088: Sensitivity of cancer cells to oncolytic viruses is defined by IWS1 phosphorylation dependent epigenetic regulation of U2AF2 splicing and nucleocytoplasmic export of type I IFN transcripts
44. Multiomics Integration Elucidates Metabolic Modulators of Drug Resistance in Lymphoma
45. IWS1 phosphorylation by AKT3 controls nuclear export of type I IFN mRNAs and sensitivity to oncolytic viral infection, by regulating the alternative RNA splicing of U2AF2
46. Abstract PO-011: IWS1 phosphorylation promotes tumor growth and predicts poor prognosis in EGFR mutant lung adenocarcinoma patients, through the epigenetic regulation of U2AF2 RNA splicing
47. Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma
48. Abstract 3649: Alternative RNA splicing of U2AF2, induced by AKT3-phosphorylated IWS1, promotes tumor growth, by activating a CDCA5-pERK positive feedback loop
49. Phospho-IWS1-dependent U2AF2 splicing is cell-cycle-regulated, promotes proliferation and predicts poor prognosis of EGFR- mutant lung adenocarcinoma
50. Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.